Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Telstar Provides Safety Cabinets to NUI Galway’s Biomedical Research Facility

Published: Wednesday, March 19, 2014
Last Updated: Wednesday, March 19, 2014
Bookmark and Share
The new, recently inaugurated research facility, which is directed towards cancer research, regenerative medicine and glycosciences, takes its place as one of five global hubs in the medtech sector.

A complete package comprising 63 cabinets developed by Telstar has been delivered to the new Biomedical Science Research Facility at the National University of Ireland in Galway (NUI Galway).

The activities of NUI Galway’s Biomedical Science Research Facility are specifically directed towards cancer research, regenerative medicine and glycosciences.

The cabinets provided by Telstar have been designed considering specific bioprocessing applications in the medical and clinical research field.

The suite of cabinets provided by Telstar represent a new generation of innovative biological safety cabinets designed to work in research environments such as tissue culture suites, radiochemistry, flow cytometry, screening core, sample preparation and biomimic areas.

The cabinets developed by Telstar for NUI Galway’s Biomedical Science Research Facility are more compact and optimize the usable work area in laboratories with limited space.

The cabinet design offers a body 20% smaller than the market average while maintaining standard work space.

Intended for the laminar flow manipulation of microorganisms with biological risk levels 2 and 3, the new range of Telstar safety cabinets offers an ergonomic design that adapts easily to small spaces, especially in laboratories with low ceilings and where several pieces of equipment need to be used in the same area.

Of the total of cabinets designed by Telstar, 57 of them correspond to Telstar Bio II Advance range, the class II cabinet designed in accordance EN12469 standard, and 6 units of EF B range of class II B2 cabinets in accordance with NSF49 standard.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
New Method of Cancer Immunotherapy
Stanford chemists have dicovered a new form of cancer immunotherapy using sugar presence manipulation.
Vortex Ring Freezing Applications
Accidental lab discovery could aid cell delivery and cell-free protein production.
Examining Immune Memory
Researchers investigate the 'storage/research for the future' functions of antibodies and understanding of B cells.
Expanding the Stable of Workhorse Yeasts
New genome sequences target the next generation of yeasts with improved biotechnology uses.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Blocking the Migration of Cancer Cells to Destroy Them
Scientists in Geneva developed an antibody able to fight off lymphomas.
Mutations Linked to Immunotherapy Resistance
Researchers uncover mutations in tumors of three patients with advanced melanoma that allowed the tumors to become resistant to the immune checkpoint inhibitor pembrolizumab (Keytruda®).
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!